This site is intended for Healthcare professionals only.

MedCom GmbH and Hitachi Medical Systems Europe Announce an Agreement to Distribute BiopSee®, MedCom’s Fusion Imaging System for Stereotactic, Navigated, Targeted Prostate Biopsy & Therapy Guidance, for use in Conjunction With Hitachi Ultrasound Systems


MedCom GmbH and Hitachi Medical Systems Europe Announce an Agreement to Distribute BiopSee®, MedCom’s Fusion Imaging System for Stereotactic, Navigated, Targeted Prostate Biopsy & Therapy Guidance, for use in Conjunction With Hitachi Ultrasound Systems

Switzerland: MedCom GmbH, Darmstadt, Germany and Hitachi Medical Systems Europe, Zug, Switzerland, announce an agreement to distribute through Hitachi’s subsidiaries sales network in Europe BiopSee®, MedCom’s fusion imaging system for stereo tactic, navigated, targeted prostate biopsy & therapy guidance, for use in conjunction with Hitachi ultrasound systems. Hitachi will be the sole distributor of the BiopSee® products in this territory for Hitachi’s installed base and when bundled with Hitachi’s products.

BiopSee® fusion imaging station combines multi-parametric MRI with real-time ultrasound. It offers thereby exceptional precision in stereotactic and navigated interventions with intuitive workflow that can bring state-of-the-art technology to everyday urology practice. The BiopSee®software supports 3D ultrasound image acquisition, rigid/elastic fusion with MRI, planning, navigation, reporting of interventional procedures, and interfaces to focal therapy devices. An electronically tracked stepper provides millimetric precision for a transperineal approach, while a magnetically tracked freehand probe can be used for navigated TRUS and abdominal procedures.

The combined forces of the MedCom BiopSee® system, powered by urology’s Gold Standard ultrasound from Hitachi, offer “the best of both worlds” to medical practitioners and patients alike: the superior quality of Hitachi’s ultrasound with its wide variety of available transducers together with BiopSee’s® intuitive workflow, documentation and reporting, opening new possibilities for future patient management. ‘I am excited at the potential of this partnership to bring new and innovative clinical solutions to our customers, said Mr. Chris Japp, President & CEO of Hitachi Medical Systems Europe.

The agreement allows Hitachi to respond rapidly to market needs providing flexible solutions for improved diagnostic and therapeutic image guidance in the field of prostate management.

Hitachi Medical Systems Europe are showcasing the combined Noblus and BiopSee systems at the 2016 European Association of Urology annual meeting in Munich, March 12th-14th, 2016, Booth # E16. In addition you can see & test both systems at the ESU/ESUT/ESUI Hands-on training in MRI Fusion, ICM building, Hall B0, level 0, Sunday, March 13th, 10.00-12.00 (HOT 29) and 14.00-16.00 (HOT 30).



Source: PRNewswire
0 comment(s) on MedCom GmbH and Hitachi Medical Systems Europe Announce an Agreement to Distribute BiopSee®, MedCom’s Fusion Imaging System for Stereotactic, Navigated, Targeted Prostate Biopsy & Therapy Guidance, for use in Conjunction With Hitachi Ultrasound Systems

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted